What is the appropriate injectable ondansetron dose for a 4-year-old child weighing 14 kg?

Injectable Ondansetron Dosing for 14 kg, 4-Year-Old Child

For a 4-year-old child weighing 14 kg, administer ondansetron 0.1 mg/kg IV (1.4 mg) for postoperative nausea/vomiting or 0.15 mg/kg IV (2.1 mg) for chemotherapy-induced nausea/vomiting.

Context-Specific Dosing

The appropriate dose depends on the clinical indication:

For Postoperative Nausea and Vomiting (PONV)

• Dose: 0.1 mg/kg IV (1.4 mg for this 14 kg child)
• Maximum single dose: 4 mg
• Administer over at least 30 seconds 1
• This dose is FDA-approved and supported by multiple pediatric trials 1, 2

Evidence basis: The FDA label specifically states that pediatric patients weighing ≤40 kg should receive 0.1 mg/kg for PONV 1. Research confirms this dose is highly effective, with 78% of children experiencing no further emetic episodes within 2 hours and 53% remaining emesis-free for 24 hours 2.

For Chemotherapy-Induced Nausea and Vomiting (CINV)

• Dose: 0.15 mg/kg IV (2.1 mg for this 14 kg child)
• Administer three doses: first dose 30 minutes before chemotherapy, then at 4 and 8 hours after the first dose
• Each dose given over 15 minutes 1

Evidence basis: FDA trials in 75 pediatric cancer patients aged 6-48 months demonstrated 56% complete response (no emetic episodes) on Day 1 with this regimen 1.

For Acute Gastroenteritis with Vomiting

• Dose: 0.1 mg/kg oral or IV (1.4 mg for this 14 kg child)
• Single dose administration
• Oral route preferred if tolerated 3, 4

Evidence basis: Recent high-quality trials show single-dose ondansetron reduces vomiting episodes and IV rehydration needs in dehydrated children 3, 4. The number needed to treat is 4 to prevent continued vomiting 3.

Dose-Response Considerations

Important caveat: Multiple pediatric studies demonstrate that lower doses are equally effective for PONV. Research shows 0.05 mg/kg is as effective as 0.1 mg/kg or 0.15 mg/kg for postoperative emesis 5, 6. However, the FDA-approved dose remains 0.1 mg/kg, which provides a safety margin and is the standard of care 1.

Administration Guidelines

• IV administration: Give over at least 30 seconds for PONV 1
• For chemotherapy: Give over 15 minutes 1
• Timing for PONV prophylaxis: Administer immediately before anesthesia induction
• Timing for established vomiting: Administer as soon as vomiting occurs

Safety Profile

Ondansetron is well-tolerated in this age group with minimal adverse effects:

• Most common: headache (9%), diarrhea (8%) 1
• Serious adverse events are rare
• No dose adjustment needed for renal impairment 1
• QT prolongation risk is minimal at standard pediatric doses but avoid in patients with congenital long QT syndrome 1

Common Pitfalls to Avoid

1. Don't underdose: Using adult fixed doses (4 mg) for all children regardless of weight may result in underdosing for smaller children
2. Don't exceed maximum: For children >40 kg, cap the dose at 4 mg for PONV 1
3. Don't confuse indications: CINV requires higher doses (0.15 mg/kg) and multiple administrations, while PONV requires only 0.1 mg/kg as a single dose
4. Route matters: IV administration over 30 seconds is standard; don't give as rapid IV push